*001104219
*00520250613174233.0
*007ta
*008020424s2001    xxu           000 u eng d
*00900757cam a22002057c 4500
*019  $bl
*035  $a(EXLNZ-47BIBSYS_NETWORK)990210188984702201
*035  $a(NO-LaBS)13958351(bibid)
*035  $a(NO-TrBIB)021018898
*035  $a021018898-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*24504$aThe benefits and costs of newer drugs :$bevidence from the 1996 medical expenditure panel survey
*260  $aCambridge, Mass.$bNBER$c2001
*300  $a17, [9] s.
*4901 $aNBER working paper series$v8147
*7001 $aLichtenberg, Frank R.$_30872700
*7102 $aNational Bureau of Economic Research (Forente Stater)$_13074800
*830 0$aWorking paper series (National Bureau of Economic Research : trykt utg.)$x0898-2937$v8147$w999105437124702201$_13074900
*901  $a60
*999  $aoai:nb.bibsys.no:990210188984702202$b2021-11-14T19:48:43Z$z990210188984702202
^